Submitted for Publication: June 27, 2014; final revision received August 2, 2014; accepted August 8, 2014.
Published Online: October 9, 2014. doi:10.1001/jamaophthalmol.2014.3950.
Study concept and design: Spaide, Klancnik.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Spaide.
Critical revision of the manuscript for important intellectual content: All authors.
Administrative, technical, or material support: Spaide.
Study supervision: Spaide, Cooney.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Spaide receives consulting and royalty payments from Topcon Medical Systems. He has been a consultant to Bausch and Lomb, Teva Pharmaceuticals, and Thrombogenics. No other disclosures were reported.
Funding/Support: Funding was provided in part by the Macula Foundation, New York, New York.
Role of the Funder/Sponsor: The Macula Foundation had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.